Prognostic Value of POD24 Validation in Follicular Lymphoma Patients Initially Treated with Chemotherapy‐free Regimens in a Pooled Analysis of Three Randomized Trials of the Swiss Group for Clinical Cancer Research (SAKK)
Hematological Oncology（2019）
Key words
early progression,follicular lymphoma,POD24,immunotherapy,rituximab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined